Biosplice Therapeutics
TypePrivately held company
IndustryRegenerative medicine
Founded2008 (2008) in San Diego, USA
FounderOsman Kibar
Faterenamed from Samumed
Headquarters
San Diego, USA
Websitewww.biosplice.com

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.[1]

Samumed's products in development target novel components of the Wnt signaling pathway.[2][3][4] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[3][5]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.